Frans van den Berg

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Plasma arginine vasopressin and motor activity in major depression

Liesbeth van Londen, G.A. Kerkhof, Frans van den Berg et al. · Biological Psychiatry · 1998 · 77 citations

Medicine, Neuroscience, Psychiatry +16

A Randomized, Double‐Blind, Placebo‐Controlled, First‐Time‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects

Kelong Han, Jennifer Cremer, Robert C. Elston et al. · Clinical Pharmacology in Drug Development · 2019 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Diffusion of NaCl in meat studied by 1H and 23Na magnetic resonance imaging

Frans van den Berg, Steffen Ringgaard, Hans Stødkilde‐Jørgensen et al. · Meat Science · 2008 · 37 citations

Natural Sciences, Biophysics, Food Science +12

Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects

Jean‐Yves Gillon, Jeremy Dennison, Frans van den Berg et al. · British Journal of Clinical Pharmacology · 2021 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +10